Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The proliferation of oral anticoagulants (warfarin and DOACs) and growing indications for their use prompted the need for guidance on the management of these drugs. This document provides guidance on management at the time of a bleeding complication. This includes acute management, starting and stopping drugs, and use of reversal agents.”
“The intent of this document was to provide a framework for clinical decision making around the management of bleeding for those on oral anticoagulant therapy.”
Provides actionable strategies for managing anticoagulant-related bleeding; extends expert consensus while awaiting prospective validation.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Tomaselli et al. (2020) studied this question. The 2020 ACC Expert Consensus Decision Pathway outlines standardized clinical strategies for the management of bleeding in patients taking oral anticoagulants.
Synapse has enriched 5 related papers. Consider them for comparative context: